Why the Lowest Life Expectancy Countries Don’t Need More Pilots — They Need Execution — A decision-leadership article by Anjo De Heus

 


When we talk about life expectancy, we often treat it as a medical statistic.

It isn’t.

Life expectancy is one of the clearest indicators of whether health systems, diagnostics, workforce, and access are functioning — or failing — together.

Today, the countries with the lowest life expectancy globally are overwhelmingly concentrated in parts of Africa. In some cases, average life expectancy barely crosses 50 years.

This is not because people in these countries are biologically different.
It is not because disease is “inevitable.”
And it is certainly not because innovation doesn’t exist.

It is because systems don’t execute.

The Real Drivers Behind Low Life Expectancy

Across countries with the lowest life expectancy, the same structural issues repeat:

  • Diseases are detected too late
  • Diagnostics are centralized, expensive, or inaccessible
  • Health workers are undertrained or overstretched
  • Preventive care is almost non-existent
  • Data is fragmented or not captured at all

In other words:
People don’t die because treatments don’t exist.
They die because the pathway to detection and care is broken.

Why “More Innovation” Is Not the Answer

Ironically, many of these countries are flooded with:

  • Pilot programs
  • Innovation hubs
  • Proof-of-concept grants
  • Startup competitions

Yet life expectancy barely moves.

Why?

Because innovation without execution does not scale health outcomes.

A new technology in a lab does nothing if:

  • No one is trained to deploy it
  • It cannot be used in communities
  • It doesn’t integrate into care pathways
  • It depends on continuous donor funding

Health outcomes improve when execution becomes systemic.

Early Detection Is the Missing Lever

The fastest way to shift life expectancy is not new hospitals.
It is earlier detection, closer to where people live.

Non-invasive diagnostics — such as saliva and protein-based testing — change the equation entirely:

  • No needles
  • No labs required at the point of collection
  • Deployable by trained nurse aides or community workers
  • Suitable for chronic diseases, cancer risk, metabolic conditions, fertility, and immune health

Early detection turns healthcare from reactive to preventive — and prevention is what moves life expectancy.

Health Outcomes Scale When Three Things Move Together

From experience, sustainable impact only happens when three engines operate in parallel:

  1. Validated Technology
    Proven diagnostics that can be deployed outside tertiary hospitals
  2. Local Workforce
    Trained, certified health workers embedded in communities
  3. Adoption Pathways
    Integration into care systems, payers, and national strategies

Remove one, and the system collapses.

Life Expectancy Is the Lagging Indicator of Execution

Life expectancy doesn’t change overnight.
It changes when early detection becomes routine, when health workers are empowered, and when systems stop relying on pilots and start delivering.

If we are serious about improving life expectancy — in Africa or anywhere else — we must stop asking:

“What’s the next innovation?”

And start asking:

“What system ensures this reaches people, every day, at scale?”

Because people are not dying from lack of ideas.
They are dying from lack of execution.

Final Words

Life expectancy is not a health statistic.
It is a verdict on whether we built systems that work.

Comments

Popular posts from this blog

Launching a Healthtech Venture in the UAE: A Strategic Guide by 360Disruption

Why 360Disruption Is the Partner of Choice for Health-tech Expansion in the Gulf

Why the UAE’s Medical Device Classification System is a Game-Changer for U.S. Healthtech Companies